NEW YORK (GenomeWeb News) – Affymetrix said after the close of the market on Tuesday that second-quarter revenues increased 3 percent year over year, helped along by a $1.4 million contribution from its eBioscience acquisition.

For the three months ended June 30, revenues for the Santa Clara, Calif.-based microarray firm increased to $66.4 million, up from $64.7 million in the year-ago period. The results beat the average analyst estimate of $65.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.